These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 75600)

  • 1. New dosage regimens for HES during intensive leukapheresis.
    Mishler JM
    Transfusion; 1978; 18(1):126-7. PubMed ID: 75600
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternate dosage regimens for high molecular weight hydroxyethyl starch.
    Rock G; McCombie N
    J Clin Apher; 1985; 2(4):375-7. PubMed ID: 2415507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO; Teno RA; Gandhi JG; Newburger PE
    Vox Sang; 1984; 47(5):325-9. PubMed ID: 6209854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate dosage regimens for high-molecular-weight hydroxyethyl starch.
    Rock G; McCombie N
    Transfusion; 1985; 25(5):417-9. PubMed ID: 2413591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new method to collect granulocytes using a low dose of hydroxyethyl starch.
    Szymanski IO
    Vox Sang; 1983; 44(2):106-14. PubMed ID: 6187130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethyl starch serum levels in leukapheresis donors measured by modified periodic acid-Schiff staining technique.
    Trivedi SM; Humphrey RL; Braine HG; Frondoza CG
    Transfusion; 1984; 24(3):260-3. PubMed ID: 6203192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis.
    Bode U; Deisseroth AB
    Transfusion; 1981; 21(1):83-5. PubMed ID: 6162256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial infusion effects of hydroxyethyl starch on ESR, blood typing and crossmatching and serum amylase levels.
    Janes AW; Mishler JM; Lowes B
    Vox Sang; 1977; 32(3):131-4. PubMed ID: 67712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor.
    Huestis DW; White RF; Price MJ; Inman M
    Transfusion; 1975; 15(6):559-64. PubMed ID: 53922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema multiforme following the infusion of hydroxyethyl starch.
    Klein RE; Mogollon G
    Transfusion; 1984; 24(2):166-7. PubMed ID: 6200969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting the optimal dose of low-molecular-weight hydroxyethyl starch (Pentastarch) for granulocyte collection.
    Strauss RG; Villhauer PJ; Imig KM; Eckermann I; Gupta SD; Thomson DS
    Transfusion; 1987; 27(4):350-2. PubMed ID: 2440159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological characteristics of the sequelae from the parenteral administration of solutions of hydroxyethyl starch].
    Prostakova TM; Glasko EN; Khokhlova MP; Polushina TV
    Arkh Patol; 1986; 48(7):43-7. PubMed ID: 2428336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients.
    Moggio RA; Rha CC; Somberg ED; Praeger PI; Pooley RW; Reed GE
    Crit Care Med; 1983 Dec; 11(12):943-5. PubMed ID: 6196155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the effects of hydroxyethyl starch on the blood coagulation system.
    Strauss RG
    Transfusion; 1981; 21(3):299-302. PubMed ID: 6165107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch in CABG.
    Diehl JT
    Ann Thorac Surg; 1985 Jan; 39(1):97-8. PubMed ID: 2578278
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury.
    Zikria BA; Subbarao C; Oz MC; Popilkis SJ; Sachdev R; Chauhan P; Freeman HP; King TC
    Arch Surg; 1990 Jul; 125(7):930-4. PubMed ID: 1695089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
    Schneider R; Hacke W; Kiesewetter H; Jung F
    Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyethyl starch: an agent for hypovolemic shock treatment.
    Mishler JM; Borberg H; Emerson PM; Gross R
    J Surg Res; 1977 Oct; 23(4):239-45. PubMed ID: 70572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.